The three-pillar matrix of patient blood management

‘Muse before you Transfuse’ For the majority of patients undergoing uncomplicated elective surgery, and in most cases of cancer chemotherapy, it should be possible to minimize or avoid blood transfusion by a standard of care that focuses on the management of a patient's own blood by optimizing...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ISBT science series 2015-04, Vol.10 (S1), p.286-294
1. Verfasser: Isbister, J. P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 294
container_issue S1
container_start_page 286
container_title ISBT science series
container_volume 10
creator Isbister, J. P.
description ‘Muse before you Transfuse’ For the majority of patients undergoing uncomplicated elective surgery, and in most cases of cancer chemotherapy, it should be possible to minimize or avoid blood transfusion by a standard of care that focuses on the management of a patient's own blood by optimizing and preserving haematopoietic reserves and tolerating deficiencies in reserves. Patient blood management is not an intervention or an alternative to allogeneic blood transfusion; it is sound evidence‐based clinical practice. Patient blood management improves clinical outcomes and as a corollary minimizes or avoids unnecessary allogeneic blood transfusions, reduces risks and helps contain health costs. The use of some autologous transfusion techniques, erythropoiesis‐stimulating agents and antifibrinolytic agents may be regarded as transfusion alternatives, but also bring with them potential hazards and costs that need balancing in the same manner as the decision to transfuse. Managing the triad of haematological risk factors for surgical patients, that is anaemia, haemorrhage and transfusion, is addressed by focusing on the three pillars of patient blood management. Maximizing total red cell mass, minimizing blood loss and tolerating of anaemia are of the essence. Most of the core principles of patient blood management come from a sound understanding of physiological and pathophysiological knowledge of haemopoiesis, haemostasis and oxygen transport and the causative mechanisms of the well‐understood hazards of blood transfusion. The concept of personalized medicine is best epitomized by Sir William Osler in his aphorism: ‘It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has’.
doi_str_mv 10.1111/voxs.12135
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1672625054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3652854651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2695-22344828721ce72c35559d16b90738628051b41bf4b3f56db6cb24e24756e63</originalsourceid><addsrcrecordid>eNp9kE9PwkAQxTdGExG9-AmaeDMpdvZvORpUMBLUQJTbZrdspVjYulsUvr2LVY7OZSYvvzeTeQidQ9KBUFefduM7gIGwA9QCwSDGKaaH-xn4MTrxfpEkjKaCthCZzE1Uz50xcVWUpXLRUtWu2EQ2jypVF2ZVR7q0dhb0lXozyyCcoqNcld6c_fY2Gt_dTnqDePjYv-9dD-MM8y6LMSaUpjgVGDIjcEYYY90ZcN1NBEk5ThMGmoLOqSY54zPNM42pwVQwbjhpo4tma-Xsx9r4Wi7s2q3CQQlcYI5Z-CFQlw2VOeu9M7msXLFUbishkbtI5C4S-RNJgKGBv4rSbP8h5cvjdPzniRtP4Wuz2XuUe5dcEMHk66gvH54Gz9MbGMkJ-QY24XDh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672625054</pqid></control><display><type>article</type><title>The three-pillar matrix of patient blood management</title><source>Access via Wiley Online Library</source><creator>Isbister, J. P.</creator><creatorcontrib>Isbister, J. P.</creatorcontrib><description>‘Muse before you Transfuse’ For the majority of patients undergoing uncomplicated elective surgery, and in most cases of cancer chemotherapy, it should be possible to minimize or avoid blood transfusion by a standard of care that focuses on the management of a patient's own blood by optimizing and preserving haematopoietic reserves and tolerating deficiencies in reserves. Patient blood management is not an intervention or an alternative to allogeneic blood transfusion; it is sound evidence‐based clinical practice. Patient blood management improves clinical outcomes and as a corollary minimizes or avoids unnecessary allogeneic blood transfusions, reduces risks and helps contain health costs. The use of some autologous transfusion techniques, erythropoiesis‐stimulating agents and antifibrinolytic agents may be regarded as transfusion alternatives, but also bring with them potential hazards and costs that need balancing in the same manner as the decision to transfuse. Managing the triad of haematological risk factors for surgical patients, that is anaemia, haemorrhage and transfusion, is addressed by focusing on the three pillars of patient blood management. Maximizing total red cell mass, minimizing blood loss and tolerating of anaemia are of the essence. Most of the core principles of patient blood management come from a sound understanding of physiological and pathophysiological knowledge of haemopoiesis, haemostasis and oxygen transport and the causative mechanisms of the well‐understood hazards of blood transfusion. The concept of personalized medicine is best epitomized by Sir William Osler in his aphorism: ‘It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has’.</description><identifier>ISSN: 1751-2816</identifier><identifier>EISSN: 1751-2824</identifier><identifier>DOI: 10.1111/voxs.12135</identifier><language>eng</language><publisher>Oxford: Blackwell Publishing Ltd</publisher><subject>Blood ; Blood transfusions ; patient blood management ; personalized medicine ; transfusion medicine ; transfusion safety</subject><ispartof>ISBT science series, 2015-04, Vol.10 (S1), p.286-294</ispartof><rights>2015 International Society of Blood Transfusion</rights><rights>Copyright ISBT Science Series © 2015 International Society of Blood Transfusion</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2695-22344828721ce72c35559d16b90738628051b41bf4b3f56db6cb24e24756e63</citedby><cites>FETCH-LOGICAL-c2695-22344828721ce72c35559d16b90738628051b41bf4b3f56db6cb24e24756e63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fvoxs.12135$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fvoxs.12135$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Isbister, J. P.</creatorcontrib><title>The three-pillar matrix of patient blood management</title><title>ISBT science series</title><addtitle>VOXS</addtitle><description>‘Muse before you Transfuse’ For the majority of patients undergoing uncomplicated elective surgery, and in most cases of cancer chemotherapy, it should be possible to minimize or avoid blood transfusion by a standard of care that focuses on the management of a patient's own blood by optimizing and preserving haematopoietic reserves and tolerating deficiencies in reserves. Patient blood management is not an intervention or an alternative to allogeneic blood transfusion; it is sound evidence‐based clinical practice. Patient blood management improves clinical outcomes and as a corollary minimizes or avoids unnecessary allogeneic blood transfusions, reduces risks and helps contain health costs. The use of some autologous transfusion techniques, erythropoiesis‐stimulating agents and antifibrinolytic agents may be regarded as transfusion alternatives, but also bring with them potential hazards and costs that need balancing in the same manner as the decision to transfuse. Managing the triad of haematological risk factors for surgical patients, that is anaemia, haemorrhage and transfusion, is addressed by focusing on the three pillars of patient blood management. Maximizing total red cell mass, minimizing blood loss and tolerating of anaemia are of the essence. Most of the core principles of patient blood management come from a sound understanding of physiological and pathophysiological knowledge of haemopoiesis, haemostasis and oxygen transport and the causative mechanisms of the well‐understood hazards of blood transfusion. The concept of personalized medicine is best epitomized by Sir William Osler in his aphorism: ‘It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has’.</description><subject>Blood</subject><subject>Blood transfusions</subject><subject>patient blood management</subject><subject>personalized medicine</subject><subject>transfusion medicine</subject><subject>transfusion safety</subject><issn>1751-2816</issn><issn>1751-2824</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kE9PwkAQxTdGExG9-AmaeDMpdvZvORpUMBLUQJTbZrdspVjYulsUvr2LVY7OZSYvvzeTeQidQ9KBUFefduM7gIGwA9QCwSDGKaaH-xn4MTrxfpEkjKaCthCZzE1Uz50xcVWUpXLRUtWu2EQ2jypVF2ZVR7q0dhb0lXozyyCcoqNcld6c_fY2Gt_dTnqDePjYv-9dD-MM8y6LMSaUpjgVGDIjcEYYY90ZcN1NBEk5ThMGmoLOqSY54zPNM42pwVQwbjhpo4tma-Xsx9r4Wi7s2q3CQQlcYI5Z-CFQlw2VOeu9M7msXLFUbishkbtI5C4S-RNJgKGBv4rSbP8h5cvjdPzniRtP4Wuz2XuUe5dcEMHk66gvH54Gz9MbGMkJ-QY24XDh</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Isbister, J. P.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>201504</creationdate><title>The three-pillar matrix of patient blood management</title><author>Isbister, J. P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2695-22344828721ce72c35559d16b90738628051b41bf4b3f56db6cb24e24756e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Blood</topic><topic>Blood transfusions</topic><topic>patient blood management</topic><topic>personalized medicine</topic><topic>transfusion medicine</topic><topic>transfusion safety</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Isbister, J. P.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><jtitle>ISBT science series</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Isbister, J. P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The three-pillar matrix of patient blood management</atitle><jtitle>ISBT science series</jtitle><addtitle>VOXS</addtitle><date>2015-04</date><risdate>2015</risdate><volume>10</volume><issue>S1</issue><spage>286</spage><epage>294</epage><pages>286-294</pages><issn>1751-2816</issn><eissn>1751-2824</eissn><abstract>‘Muse before you Transfuse’ For the majority of patients undergoing uncomplicated elective surgery, and in most cases of cancer chemotherapy, it should be possible to minimize or avoid blood transfusion by a standard of care that focuses on the management of a patient's own blood by optimizing and preserving haematopoietic reserves and tolerating deficiencies in reserves. Patient blood management is not an intervention or an alternative to allogeneic blood transfusion; it is sound evidence‐based clinical practice. Patient blood management improves clinical outcomes and as a corollary minimizes or avoids unnecessary allogeneic blood transfusions, reduces risks and helps contain health costs. The use of some autologous transfusion techniques, erythropoiesis‐stimulating agents and antifibrinolytic agents may be regarded as transfusion alternatives, but also bring with them potential hazards and costs that need balancing in the same manner as the decision to transfuse. Managing the triad of haematological risk factors for surgical patients, that is anaemia, haemorrhage and transfusion, is addressed by focusing on the three pillars of patient blood management. Maximizing total red cell mass, minimizing blood loss and tolerating of anaemia are of the essence. Most of the core principles of patient blood management come from a sound understanding of physiological and pathophysiological knowledge of haemopoiesis, haemostasis and oxygen transport and the causative mechanisms of the well‐understood hazards of blood transfusion. The concept of personalized medicine is best epitomized by Sir William Osler in his aphorism: ‘It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has’.</abstract><cop>Oxford</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/voxs.12135</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1751-2816
ispartof ISBT science series, 2015-04, Vol.10 (S1), p.286-294
issn 1751-2816
1751-2824
language eng
recordid cdi_proquest_journals_1672625054
source Access via Wiley Online Library
subjects Blood
Blood transfusions
patient blood management
personalized medicine
transfusion medicine
transfusion safety
title The three-pillar matrix of patient blood management
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T23%3A50%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20three-pillar%20matrix%20of%20patient%20blood%20management&rft.jtitle=ISBT%20science%20series&rft.au=Isbister,%20J.%20P.&rft.date=2015-04&rft.volume=10&rft.issue=S1&rft.spage=286&rft.epage=294&rft.pages=286-294&rft.issn=1751-2816&rft.eissn=1751-2824&rft_id=info:doi/10.1111/voxs.12135&rft_dat=%3Cproquest_cross%3E3652854651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1672625054&rft_id=info:pmid/&rfr_iscdi=true